首页> 外国专利> T Mesothelin-specific chimeric antigen receptor and T lymphocyte expressing this chimeric antigen receptor

T Mesothelin-specific chimeric antigen receptor and T lymphocyte expressing this chimeric antigen receptor

机译:T间皮素特异性嵌合抗原受体和表达该嵌合抗原受体的T淋巴细胞

摘要

The present invention relates to a chimeric antigen receptor, and immune cells expressing the same. More specifically, the present invention relates to a chimeric antigen receptor, and immune cells, preferably T cells, which express the same. The chimeric antigen receptor comprises: an anti-mesothelin antibody or a fragment thereof; a signal peptide of CD8α; a hinge of CD28 or CD8α; a transmembrane domain of CD28 or CD8α; and an intracellular signaling domain including intracellular signal region sequences of CD28, 4-1BB, and CD3ζ. According to the present invention, a chimeric antigen receptor, and T cells expressing the same which are immune cells are configured to exhibit excellent anticancer activities, and thus, can be effectively used in treating cancer.
机译:嵌合抗原受体和表达该抗原的免疫细胞技术领域本发明涉及嵌合抗原受体和表达该抗原的免疫细胞。更具体地,本发明涉及嵌合抗原受体和表达该嵌合抗原受体的免疫细胞,优选T细胞。嵌合抗原受体包括:抗间皮素抗体或其片段;和CD8α的信号肽; CD28或CD8α的铰链; CD28或CD8α的跨膜结构域;细胞内信号传导域包括CD28、4-1BB和CD3ζ的细胞内信号区域序列。根据本发明,嵌合抗原受体和表达该嵌合抗原受体的T细胞是免疫细胞,被构造成表现出优异的抗癌活性,因此可以有效地用于治疗癌症。

著录项

  • 公开/公告号KR102070016B1

    专利类型

  • 公开/公告日2020-01-29

    原文格式PDF

  • 申请/专利权人 GREENCROSSCELL;

    申请/专利号KR20190007422

  • 申请日2019-01-21

  • 分类号C07K16/30;A61K35/17;A61P35;C07K14/705;C12N15/86;C12N5/0783;

  • 国家 KR

  • 入库时间 2022-08-21 11:05:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号